PPARγ-A Factor Linking Metabolically Unhealthy Obesity with Placental Pathologies
Sebastian Kwiatkowski1, Anna Kajdy2, Katarzyna Stefańska3
1Clinical Department of Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland.
Insights
Obesity contributes to preeclampsia by affecting both adipose tissue and placental development. Aberrantly low activity of the master adipogenesis regulator PPARγ is a common link between these conditions.
Area of Science:
- Reproductive biology
- Metabolic disorders
- Pathophysiology
Background:
- Obesity is a global health concern with significant mortality implications.
- Overweight and obesity rates are increasing, particularly in Europe, affecting women of reproductive age.
- Obesity is a known risk factor for placental development disorders, including preeclampsia.
Purpose of the Study:
- To investigate the link between adipose tissue pathologies and aberrant placental development in preeclampsia.
- To identify common molecular mechanisms, such as PPARγ activity, shared by obesity and preeclampsia.
- To provide insights for the prevention and treatment of preeclampsia in obese pregnant women.
Main Methods:
- Review of existing literature linking obesity, adipose tissue, placental development, and preeclampsia.
- Analysis of the role of Peroxisome proliferator-activated receptor gamma (PPARγ) in adipogenesis and placental function.
- Examination of epidemiological data on obesity prevalence in Europe and its impact on pregnancy.
Main Results:
- Adipose tissue pathologies associated with obesity are linked to aberrant placental development.
- Reduced activity of PPARγ, a key regulator of adipogenesis, is implicated in both obesity and placental pathologies.
- Obesity significantly increases the risk of preeclampsia due to impaired placental development.
Conclusions:
- Shared mechanisms between obesity and preeclampsia, particularly involving PPARγ, offer potential therapeutic targets.
- Understanding these links can aid in the prevention and management of preeclampsia in obese pregnancies.
- Health education emphasizing diet and physical activity is crucial for mitigating risks associated with obesity in pregnancy.
Abstract:
Obesity is a known factor in the development of preeclampsia. This paper links adipose tissue pathologies with aberrant placental development and the resulting preeclampsia. PPARγ, a transcription factor from the ligand-activated nuclear hormone receptor family, appears to be one common aspect of both pathologies. It is the master regulator of adipogenesis in humans. At the same time, its aberrantly low activity has been observed in placental pathologies. Overweight and obesity are very serious health problems worldwide. They have negative effects on the overall mortality rate. Very importantly, they are also conducive to diseases linked to impaired placental development, including preeclampsia. More and more people in Europe are suffering from overweight (35.2%) and obesity (16%) (EUROSTAT 2021 data), some of them young women planning pregnancy. As a result, we will be increasingly encountering obese pregnant women with a considerable risk of placental development disorders, including preeclampsia. An appreciation of the mechanisms shared by these two conditions may assist in their prevention and treatment. Clearly, it should not be forgotten that health education concerning the need for a proper diet and physical activity is of utmost importance here.
More Related Videos
14:56Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Cell Specific Gene Expression
Cholesterol: Significance and Regulation
Considering cholesterol and...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
